PATENT CLAIM ANALYSIS

Application Number: 16097506
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "338000"]

Abstract:
The present invention relates to crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.

Claim (Index 14):
A method for treatment or prophylaxis of neoplastic disorders, dermatological disorders, gynaecological disorders, cardiovascular disorders, pulmonary disorders, ophthalmological disorders, neurological disorders, metabolic disorders, hepatic disorders, inflammatory disorders, autoimmune disorders or pain, comprising administering to a patient in need thereof comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition according to  claim 7 .

Metadata:
- Claim Count in Document: 42.0
- Percentile: 97.0
- Lexical Diversity: 1.30556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16097463', '16097065', '15529996', '15106073', '13856666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7267434803996945
- 35 USC 102 Novelty (BERT): 0.5138123332673331
- Combined Prediction Score: 0.7054503656864584
- Mean Citation Score: 266.679436
- Max Citation Score: 294.3370700000001
- Similarity Product: 209.7533658769179

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test